Microvascular Tissues, Inc. (MVT) is a privately held commercial stage regenerative medicine company; formed in 2014 as a management led spin-out from Tornier, Inc. (TRNX), now part of Wright Medical (WMGI).
With our evidence-based approach, we are focused on developing and commercializing products that address vascular deficiencies using vascular solutions.
Our technology platform mVASC® leverages the natural
healing mechanisms of the body by supporting the repair reconstruction and replacement of microvascular tissues.
Located in San Diego, CA.